Search research articles
Contact Us
Filters
Showing results (91-100 of 279) with videos related to
Page
of 28
Sort By:
Neurology
|
August 20, 2017
Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults
Ge Li, Cynthia L Mayer, Daniel Morelli, et al.
JAMA Neurology
|
July 26, 2016
Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy
Liang Wang, Tammie L Benzinger, Yi Su, et al.
Journal of Alzheimer'S Disease : JAD
|
February 18, 2009
Performance characteristics of plasma amyloid-beta 40 and 42 assays
Olivia I Okereke, Weiming Xia, Michael C Irizarry, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 16, 2017
Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
Suzanne E Schindler, Courtney L Sutphen, Charlotte Teunissen, et al.
Neurobiology of Aging
|
May 9, 2017
Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease
Suzanne E Schindler, Mateusz S Jasielec, Hua Weng, et al.
Molecular Neurodegeneration
|
April 27, 2012
Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer's disease subjects
Saori Hata, Miyako Taniguchi, Yi Piao, et al.
Annals of Neurology
|
July 12, 2016
Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
Andrei G Vlassenko, Lena McCue, Mateusz S Jasielec, et al.
Annals of Neurology
|
May 1, 2016
Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid
Yo-El S Ju, Mary Beth Finn, Courtney L Sutphen, et al.
The American Journal of Pathology
|
October 7, 2004
ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
Anne M Fagan, Erin Christopher, Jennie W Taylor, et al.
JAMA Neurology
|
August 21, 2013
Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity
Liang Wang, Matthew R Brier, Abraham Z Snyder, et al.
Page
of 28
Search research articles
Search
Showing results (91-100 of 279) with videos related to
Sort By:
Page
of 28
Neurology
|
August 20, 2017
Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults
Ge Li, Cynthia L Mayer, Daniel Morelli, et al.
JAMA Neurology
|
July 26, 2016
Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy
Liang Wang, Tammie L Benzinger, Yi Su, et al.
Journal of Alzheimer'S Disease : JAD
|
February 18, 2009
Performance characteristics of plasma amyloid-beta 40 and 42 assays
Olivia I Okereke, Weiming Xia, Michael C Irizarry, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 16, 2017
Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
Suzanne E Schindler, Courtney L Sutphen, Charlotte Teunissen, et al.
Neurobiology of Aging
|
May 9, 2017
Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease
Suzanne E Schindler, Mateusz S Jasielec, Hua Weng, et al.
Molecular Neurodegeneration
|
April 27, 2012
Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer's disease subjects
Saori Hata, Miyako Taniguchi, Yi Piao, et al.
Annals of Neurology
|
July 12, 2016
Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
Andrei G Vlassenko, Lena McCue, Mateusz S Jasielec, et al.
Annals of Neurology
|
May 1, 2016
Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid
Yo-El S Ju, Mary Beth Finn, Courtney L Sutphen, et al.
The American Journal of Pathology
|
October 7, 2004
ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
Anne M Fagan, Erin Christopher, Jennie W Taylor, et al.
JAMA Neurology
|
August 21, 2013
Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity
Liang Wang, Matthew R Brier, Abraham Z Snyder, et al.
Page
of 28